These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
365 related articles for article (PubMed ID: 8944829)
1. Effects of losartan on vasoconstrictor responses to angiotensin II in the forearm vascular bed of healthy volunteers. Baan J; Chang PC; Vermeij P; Pfaffendorf M; van Zwieten PA Cardiovasc Res; 1996 Nov; 32(5):973-9. PubMed ID: 8944829 [TBL] [Abstract][Full Text] [Related]
2. Comparison of angiotensin-converting enzyme inhibition with angiotensin II receptor antagonism in the human forearm. Cockcroft JR; Sciberras DG; Goldberg MR; Ritter JM J Cardiovasc Pharmacol; 1993 Oct; 22(4):579-84. PubMed ID: 7505360 [TBL] [Abstract][Full Text] [Related]
3. Forearm vasodilator response to angiotensin II in elderly women receiving candesartan: role of AT(2)- receptors. Phoon S; Howes LG J Renin Angiotensin Aldosterone Syst; 2002 Mar; 3(1):36-9. PubMed ID: 11984746 [TBL] [Abstract][Full Text] [Related]
4. Endogenous angiotensin II contributes to basal peripheral vascular tone in sodium deplete but not sodium replete man. Newby DE; Masumori S; Johnston NR; Boon NA; Webb DJ Cardiovasc Res; 1997 Nov; 36(2):268-75. PubMed ID: 9463638 [TBL] [Abstract][Full Text] [Related]
5. Effects of angiotensin II and losartan in the forearm of patients with essential hypertension. Baan J; Chang PC; Vermeij P; Pfaffendorf M; van Zwieten PA J Hypertens; 1998 Sep; 16(9):1299-305. PubMed ID: 9746117 [TBL] [Abstract][Full Text] [Related]
6. Regulation of angiotensin II receptor AT1 subtypes in renal afferent arterioles during chronic changes in sodium diet. Ruan X; Wagner C; Chatziantoniou C; Kurtz A; Arendshorst WJ J Clin Invest; 1997 Mar; 99(5):1072-81. PubMed ID: 9062366 [TBL] [Abstract][Full Text] [Related]
7. Comparative vasoconstrictor effects of angiotensin II, III, and IV in human isolated saphenous vein. Li Q; Feenstra M; Pfaffendorf M; Eijsman L; van Zwieten PA J Cardiovasc Pharmacol; 1997 Apr; 29(4):451-6. PubMed ID: 9156353 [TBL] [Abstract][Full Text] [Related]
8. Regulation of peripheral vascular tone in patients with heart failure: contribution of angiotensin II. Newby DE; Goodfield NE; Flapan AD; Boon NA; Fox KA; Webb DJ Heart; 1998 Aug; 80(2):134-40. PubMed ID: 9813557 [TBL] [Abstract][Full Text] [Related]
9. Drug concentration response relationships in normal volunteers after oral administration of losartan, an angiotensin II receptor antagonist. Munafo A; Christen Y; Nussberger J; Shum LY; Borland RM; Lee RJ; Waeber B; Biollaz J; Brunner HR Clin Pharmacol Ther; 1992 May; 51(5):513-21. PubMed ID: 1587065 [TBL] [Abstract][Full Text] [Related]
10. Chronic blockade of AT2-subtype receptors prevents the effect of angiotensin II on the rat vascular structure. Levy BI; Benessiano J; Henrion D; Caputo L; Heymes C; Duriez M; Poitevin P; Samuel JL J Clin Invest; 1996 Jul; 98(2):418-25. PubMed ID: 8755652 [TBL] [Abstract][Full Text] [Related]
11. Influence of indomethacin and L-NMMA on vascular tone and angiotensin II-induced vasoconstriction in the human forearm. Baan J; Chang PC; Vermeij P; Pfaffendorf M; van Zwieten PA Blood Press; 1997 Sep; 6(5):279-85. PubMed ID: 9359998 [TBL] [Abstract][Full Text] [Related]
12. Differential regulation of angiotensin II and losartan binding sites in glomeruli and mesangial cells. Chansel D; Bizet T; Vandermeersch S; Pham P; Levy B; Ardaillou R Am J Physiol; 1994 Mar; 266(3 Pt 2):F384-93. PubMed ID: 8160786 [TBL] [Abstract][Full Text] [Related]
13. Acute hypoxic pulmonary vasoconstriction in man is attenuated by type I angiotensin II receptor blockade. Kiely DG; Cargill RI; Lipworth BJ Cardiovasc Res; 1995 Dec; 30(6):875-80. PubMed ID: 8746201 [TBL] [Abstract][Full Text] [Related]
14. Effect of the AT1-receptor antagonists losartan, irbesartan, and telmisartan on angiotensin II-induced facilitation of sympathetic neurotransmission in the rat mesenteric artery. Balt JC; Mathy MJ; Nap A; Pfaffendorf M; van Zwieten PA J Cardiovasc Pharmacol; 2001 Jul; 38(1):141-8. PubMed ID: 11444497 [TBL] [Abstract][Full Text] [Related]
15. Human plasma protein binding of the angiotensin II receptor antagonist losartan potassium (DuP 753/MK 954) and its pharmacologically active metabolite EXP3174. Christ DD J Clin Pharmacol; 1995 May; 35(5):515-20. PubMed ID: 7657853 [TBL] [Abstract][Full Text] [Related]
16. Paraventricular nucleus administration of DuP753 or PD123319 inhibits the effects of angiotensin on water and sodium intake. do-Prado MH; Camargo GM; Renzi A; Saad WA; Luiz AC; Queiróz RC; Camargo LA Braz J Med Biol Res; 1996 Nov; 29(11):1499-502. PubMed ID: 9196552 [TBL] [Abstract][Full Text] [Related]
17. The role of angiotensin AT1 receptors in the diuretic, natriuretic, kaliuretic and blood pressure responses induced by angiotensin II activation of the median preoptic nucleus in conscious rats. Ferreira-do-Vale C; Renzi A; Camargo GP; Saad WA; Luiz AC; Menani JV; Silveira JE; Camargo LA Braz J Med Biol Res; 1995 Oct; 28(10):1097-101. PubMed ID: 8634683 [TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo effects of UP 269-6, a new potent orally active nonpeptide angiotensin II receptor antagonist, on vascular smooth muscle cell proliferation. Virone-Oddos A; Desangle V; Provost D; Cazes M; Caussade F; Cloarec A Br J Pharmacol; 1997 Feb; 120(3):488-94. PubMed ID: 9031754 [TBL] [Abstract][Full Text] [Related]
19. Losartan potassium, a nonpeptide antagonist of angiotensin II, chronically administered p.o. does not readily cross the blood-brain barrier. Bui JD; Kimura B; Phillips MI Eur J Pharmacol; 1992 Aug; 219(1):147-51. PubMed ID: 1397042 [TBL] [Abstract][Full Text] [Related]
20. Effects of the angiotensin type I receptor antagonist, losartan, on systemic and regional vascular responses to lower body negative pressure in healthy volunteers. Duranteau J; Pussard E; Berdeaux A; Giudicelli JF Br J Clin Pharmacol; 1995 Nov; 40(5):431-8. PubMed ID: 8703646 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]